| Potential immunomodulatory effects of CAS+ IMD monoclonal antibody cocktail in hospitalized patients with COVID-19 B Wang, J Golubov, EM Oswald, P Poon, Q Wei, C Lett, F Shehadeh, ... EBioMedicine 108, 2024 | | 2024 |
| Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19 C Reilly, E Mylonakis, R Dewar, B Young, J Nordwall, S Bhagani, P Chia, ... The Journal of infectious diseases, jiae452, 2024 | | 2024 |
| 53160 Risk of Infection in patients with Hidradenitis Suppurativa on Biologics or other immunomodulators: A Systematic Review and Meta-analysis I Lazaridou, A Vassilopoulos, S Vassilopoulos, F Shehadeh, M Kalligeros, ... Journal of the American Academy of Dermatology 91 (3), AB302, 2024 | | 2024 |
| Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention on Gram-negative Bacteremia J Ventres, MH Ting, DM Parente, R Rogers, AM Norris, G Benitez, ... Open Forum Infectious Diseases, ofae477, 2024 | | 2024 |
| The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument D Rofail, S Somersan-Karakaya, E Mylonakis, JY Choi, K Przydzial, ... Journal of Patient-Reported Outcomes 8 (1), 87, 2024 | | 2024 |
| Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis K Ouranos, DV Avila, EK Mylona, A Vassilopoulos, S Vassilopoulos, ... Plos one 19 (7), e0306548, 2024 | | 2024 |
| Machine learning-assisted high-throughput screening for Anti-MRSA compounds F Shehadeh, LO Felix, M Kalligeros, A Shehadeh, BB Fuchs, FM Ausubel, ... IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2024 | | 2024 |
| Molecular Dynamics Simulations Help Determine the Molecular Mechanisms of Lasioglossin-III and Its Variant Peptides’ Membrane Interfacial Interactions A Kumar, B Mishra, AD Konar, E Mylonakis, A Basu The Journal of Physical Chemistry B, 2024 | | 2024 |
| Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020 M Kalligeros, A Vassilopoulos, S Vassilopoulos, DW Victor, E Mylonakis, ... Clinical Gastroenterology and Hepatology 22 (6), 1330-1332. e4, 2024 | 27 | 2024 |
| Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study TO Jensen, TA Murray, GA Grandits, MK Jain, B Grund, K Shaw-Saliba, ... The Lancet Microbe, 2024 | | 2024 |
| Temporal trends and characteristics associated with racial, ethnic, and sex representation in COVID-19 clinical trials: A systematic review and meta-analysis M Kaczynski, A Vassilopoulos, S Vassilopoulos, A Sisti, G Benitez, ... Contemporary Clinical Trials, 107578, 2024 | | 2024 |
| In Enterobacterales bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 d K Ouranos, E Mylonakis Annals of Internal Medicine 177 (5), JC52, 2024 | | 2024 |
| In adults with post–COVID-19 conditions, a synbiotic preparation, SIM01, alleviated some symptoms at 6 mo D Gotur, E Mylonakis Annals of Internal Medicine 177 (4), JC45, 2024 | | 2024 |
| Auranofin-releasing antibacterial and antibiofilm polyurethane intravascular catheter coatings A Shukla, B Fuchs, H Liu, E Mylonakis US Patent 11,931,482, 2024 | | 2024 |
| Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19 TO Jensen, GA Grandits, MK Jain, TA Murray, B Grund, K Shaw-Saliba, ... The Journal of infectious diseases 229 (3), 671-679, 2024 | 1 | 2024 |
| Public interest trends for COVID-19 and pandemic trajectory: A time-series analysis of US state-level data PD Ziakas, E Mylonakis PLOS Digital Health 3 (3), e0000462, 2024 | | 2024 |
| Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis K Ouranos, H Saleem, S Vassilopoulos, A Vassilopoulos, EK Mylona, ... Inflammatory Bowel Diseases, izae031, 2024 | 1 | 2024 |
| Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis A Vassilopoulos, M Kalligeros, S Vassilopoulos, F Shehadeh, G Benitez, ... Digestive Diseases and Sciences 69 (3), 989-1003, 2024 | | 2024 |
| A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin HY Heo, G Zou, S Baek, JS Kim, E Mylonakis, FM Ausubel, H Gao, W Kim Advanced Science 11 (9), 2306112, 2024 | | 2024 |
| Steatotic Liver Disease: Advancing Science and Patient Care Beyond Traditions. M Kalligeros, E Mylonakis, M Noureddin Clinical Gastroenterology and Hepatology: the Official Clinical Practice …, 2024 | | 2024 |
